Abstract
Recent advances in the unique clinicopathologic entity of lymphoblastic lymphoma (and its variants) are discussed in this article, which details the natural history, molecular biology, prognosis, and outcome with various chemotherapy regimens. Improved outcome with the newer intensive chemotherapy regimens and the role of modalities such as autologous intensification, allogeneic bone marrow transplant, and radiotherapy are discussed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 51-95 |
| Number of pages | 45 |
| Journal | Hematology/Oncology Clinics of North America |
| Volume | 15 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2001 |
ASJC Scopus subject areas
- Hematology
- Oncology
Fingerprint
Dive into the research topics of 'Lymphoblastic lymphoma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS